EPICRISPR BIOTECHNOLOGIES
HQ - South San Francisco
Summary
Epicrispr Biotechnologies is a biotechnology company developing ultracompact therapies to modulate gene expression in vivo using the smallest known Cas protein, CasMINI.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 53 M
Avg. Deal Size£ 53 M
All rights reserved. Copyright © 2025 Datasite
